information for practice
news & new scholarship from around the world
gary.holden@nyu.edu
archive
about
help
«
Community Development Journal, 41, 2
|
Main
|
New England Journal of Medicine, 354, 13
»
March 30, 2006
No significant association of the 5′ end of neuregulin 1 and schizophrenia in a large Danish sample
A comprehensive genetic association and functional study of TNF in schizophrenia risk
Suicide behaviour over 18 months in recent onset schizophrenic patients: The effects of CBT
Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment
Perceptual organization in first episode schizophrenia and ultra-high-risk states
Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode
A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: Changes in psychiatric symptoms and substance use
Change in neurocognition by housing type and substance abuse among formerly homeless seriously mentally ill persons
Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication
A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics
No significant association of the 5′ end of neuregulin 1 and schizophrenia in a large Danish sample
A comprehensive genetic association and functional study of TNF in schizophrenia risk
Suicide behaviour over 18 months in recent onset schizophrenic patients: The effects of CBT
Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment
Perceptual organization in first episode schizophrenia and ultra-high-risk states
Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode
A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: Changes in psychiatric symptoms and substance use
Change in neurocognition by housing type and substance abuse among formerly homeless seriously mentally ill persons
Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication
A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics
Posted by Gary Holden at March 30, 2006 9:00 AM